The effect of tumor response on quality of life (QoL) in patients with KRAS wild-type metastatic colorectal cancer (mCRC): Analysis from the CRYSTAL study. Background: Capecitabine has established ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback